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During the last decade, significant advances have been
made in the understanding of the pathogenesis of coro-
nary atherosclerotic disease. Two facts are important:
1) the early and some of the advanced coronary athero-
sclerotic lesionsprogress very slowly,probably by means
of a complex stepwise biologic process with one of the
steps being an interaction between platelets and the ar-
terial Wall; the process can be favored by the so-called
risk factors of atherosclerotic disease, and 2) some of the
advanced coronary atherosclerotic lesions progress very
rapidly, probably by means of complicating anatomic
events, one of which is related to a thrombogenic process.
From a clinical point of view, technologic improve-
ments, such as serial coronary arteriography, reperfu-
Natural Evolution of Atherosclerotic Lesions
The International Atherosclerosis Project 0), which in-
volved 14 countries with 19 different racial groups, had the
objective of describing the incidence and natural history of
atherosclerotic lesions found in coronary arteries or the aorta
at autopsy in these different populations. In the study, 23,000
sets of coronary arteries and aortas were evaluated. The
findings demonstrated that raised fatty streaks are a universal
phenomenon in young persons in all geographic and racial
groups; however, their evolution into clinically relevant fi-
brous plaques and complicated lesions varies in incidence
and extent among different geographic and racial groups
and also among the various arterial systems, being predom-
inant in the coronary artery system (2).
In the natural history of the atherosclerotic lesion (Fig.
1 and 2), three facts are important: 1) the progression of
early coronary atherosclerotic lesions (raised fatty streaks)
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sion during the acute coronary artery syndromes, post-
mortem coronary arteriography, and methods for serial
histopathologic and histochemical studies, have brought
to light the clinical importance of the processes of plaque
rupture, dissecting hemorrhage and, most important,
thrombosis. These complicated processes appear to be
of paramount importance in the Pllthogenesis of some
of the acute coronary syndromes including unstable an-
gina, myocardial infarction and sudden coronary death.
Antithrombotic and platelet inhibitor therapy is under
investigation and appears promising in some of these
patient subsets.
(J Am Coil CardioI1985;5:175B-184B)
to clinically relevant advanced atherosclerotic lesions (such
as fibrous plaques) frequently occurs in those persons with
the so-called risk factors of atherosclerotic disease; 2) the
early and some of the advanced atherosclerotic lesions pro-
gress very slowly, probably by means of a complex stepwise
biologic process in which one of the steps is related to
interaction between platelets and the arterial wall; and 3)
some of the advanced atherosclerotic lesions progress very
rapidly, probably by means of complicating anatomic events,
one of which is related to a thrombogenic process.
Pathogenesis of Early Atherosclerotic Lesions
The major critical events in the development of the early
atherosclerotic lesions (Table 1, Fig. 1) (3) are: 1) hemo-
dynamic turbulence, endothelial injury and smooth muscle
cell proliferation; 2) interaction between platelets and the
arterial wall; 3) proliferation of fibrous tissue; and 4) ac-
cumulation of lipoproteins.
Hemodynamic tpfbulence, endothelial injury and
smooth muscle cell ppoliferation. Arterial branch points
and other areas where atherosclerotic plaques usually de-
velop have been shown to be sites of endothelial injury (4),
There is some evidence that hemodynamic factors are in-
volved in causing such focal and chronic or continuous
minimal endothelial injury. From experiments in which hy-
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Figure 1. Scheme of evolution of coronary artery
atherosclerosis . The progression of early lesions to
clinically relevant advanced lesions tends to occur
in those persons with the so-called risk factors of
atherosclerotic disease. The early and some of the
clinically relevant advanced lesions can progress to
total occlusion of an artery either through slow pro-
gression or rapidly by thrombus formation with sub-
sequent fibrotic organization.
draulic models of various flow patterns were used, it was
possible to predict from the site of maximal turbulence the
areas of predilection for occurrence of atherosclerosis within
the human aorta (5); similarly, the localization of athero-
sclerotic plaques in the coronary artery tree appears to cor-
relate with sites of hemodynamic turbulence (2,6,7). There
is increasing evidence that some of the so-called risk factors
of atherosclerotic disease may contribute to this chronic
process of endothelial injury (8).
The concept that atherosclerosis is a local response to
chronic or continuous minimal endothelial injury has also
received further support (9). Experimental endothelial injury
reproduces the full spectrum of early atherosclerotic lesions.
In such experiments, as in spontaneous atherosclerosis, one
of the first structural changes is an intimal proliferation of
smooth muscle cells that presumably derive from the media
of the artery. Because the arterial injury in these experiments
(9) was very superficial, the possibility arises that the mi-
gration and proliferation of smooth muscle cells are related
to an interaction between blood components and the injured
surface of the arterial wall.
Interaction between platelets and the arterial wall.
Evidence that platelets and other formed elements of the
blood can interact with the minimally injured vascular en-
dothelium in regions of blood turbulence has been obtained
in a number of studies . Formed elements, mainly platelets,
have been detected on the endothelial surface of arteries
from rabbits, pigs and young human subjects who died
suddenly; these elements occurred near those sites where
atherosclerosis develops (10).
Thus far, it appears that the observed attachment of plate-
lets to damaged endothelial surfaces, and particularly their
activation, depends mainly on a complex molecule related
to factor VIII (II). This molecule, called the Willebrand
A
Figure 2. Progression of coronary ar-
tery atherosclerosis. Slow progres-
sion: A, normal artery; B, fatty streak
with fibrosis; C, advanced fibrous
plaque . Rapid progression: D, occlu-
sion by thrombus formation over su-
perficial plaque damage; E , thrombus
in process of fibrotic organization.
(Reproduced from Fuster V [3], with
permission .)
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Table 1. Simplified Unified Concept of Probable Sequential
Events in Coronary Atherosclerotic Disease: Role of Platelets
and Thrombosis*
Early lesions-asymptomatic stage
Hemodynamic factors-endothelial damage
Platelet deposition
Smooth muscle cell migration and proliferation
Connective tissue synthesis
Lipid transformation and deposition
Growing lesions-angina pectoris
Progression of above (slow process)
Organization of thrombi (rapid processi'
Clinical complications
Unstable angina
Plaque rupture. thrombosis'
Myocardial infarction
Plaque rupture. thrombotic occlusion'
Sudden death
Chronic myocardial fibrosis
Myocardial infarction} . T
M di I' hemi thrombosisyocar ia ISC erma
? Microemboli
*Italic type indicates steps in which platelets and thrombosis play a
role; "events that may be prevented or diminished by use of platelet-
inhibiting drugs.
factor, is normally present in the circulating plasma and
platelets as well as in the endothelial and subendothelial
regions (probably attached to collagen fibrils), and there is
increasing evidence that it favors the platelet-arterial wall
interaction and platelet activation in such regions of endo-
thelial damage.
The possibility has been raised that when attached to the
mildly injured arterial wall, these platelets are one of the
principal factors that stimulate the smooth muscle cell pro-
liferation that occurs at the initial stages of atherosclerosis.
In experimental atherosclerosis induced by endothelial in-
jury, one of the first morphologic events is the appearance
of platelets undergoing intracytoplasmic degranulation and
adhering to the endothelial surface and subendothelial de-
nuded areas. This precedes the migration and proliferation
of smooth muscle cells (9). An important finding by Ross
et al. (12) was that a substance derived from platelets-
platelet-derived growth factor-was necessary for the pro-
liferation of smooth muscle cells and fibroblasts in culture,
and it has been assumed that this substance is one of the
main factors responsible for smooth muscle cell proliferation
in the early atherosclerotic lesions. This growth factor is a
low molecular weight, heat-stable protein that has been pu-
rified (13). Platelet-derived growth factor, platelet factor 4,
which is an antiheparin factor, and beta-thromboglobulin
are all released from the platelet alpha-granules during plate-
let activation (14). The observation that platelet factor 4 can
penetrate the vessel wall intima during the process of plate-
let-arterial wall interaction (15) is of interest, particularly
in view of the recent observation of its chemotactic prop-
erties (16). It is conceivable that, during the platelet-arterial
wall interaction, platelet factor 4 and platelet-derived growth
factor penetrate the vessel wall; then platelet factor 4 may
attract the smooth muscle cells from the media toward the
intima, and platelet-derived growth factor, together with
other growth factors, may playa role in the proliferation of
intimal smooth muscle cells.
Insight into the contribution of platelets to the initiation
of atherosclerosis has also been gained by investigating
whether inhibition of platelet function occurs in experi-
mental animals resistant to the development of atheroscle-
rosis. For several years, a breeding colony of pigs with
severely impaired platelet function in the form of homo-
zygous von Willebrand's disease has been maintained in
Rochester, Minnesota. Fuster et al. (17,18) showed that
such pigs have a marked impairment in platelet attachment
to the vascular wall, and they are resistant to the initiation
and progression of both spontaneous atherosclerosis (17)
and atherosclerosis induced by a diet mildly high in cho-
lesterol (18). However, pigs with heterozygous von Wil-
lebrand's disease and, thus, less severely impaired platelet
function are not resistant to atherosclerosis. This is con-
sistent with the idea that the presence of normal or nearly
normal platelet function may be important in the initial
stages of atherosclerosis.
Fibrous tissue formation. The formation of fibrous tis-
sue contributes significantly to the initiation of the athero-
sclerotic plaque and, most importantly, to its progression,
as discussed later. The elements making up this fibrous
tissue are collagen, proteoglycans, elastin and glycopro-
teins, and all of them appear to be synthesized by the smooth
muscle cells of the artery (19-23).
Collagen formation is the major contributor to the growth
of the atherosclerotic plaque. The glycosaminoglycans and
elastin fibers appear to be important in the binding of lipid
into the arterial wall. In addition, elastin fibers contribute
significantly to the process of calcification of the athero-
sclerotic plaque. Glycoproteins appear to be important in
certain interactions of collagen and elastin fibers.
This concept offibrous tissue synthesis assumes that the
endothelial injury and platelet deposition not only lead to
the migration and proliferation of the smooth muscle cells,
but also stimulate them to produce the synthesis components
of fibrous tissue. In addition, it appears that the chronic
pulsatile distension of the arteries also favors the synthesis
of collagen by the smooth muscle cells and, thus, the slow
progression of the atherosclerotic plaque (24).
Lipoprotein entry into and accumulation by the ar-
terial wall. The major class of lipids accumulating in the
arterial wall during atherogenesis is cholesterol esters. The
cholesterol is derived from plasma lipoproteins. Biochem-
ical studies of atherosclerotic vessels at various stages of
development have shown that whereas plasma and the nor-
mal arterial wall contain cholesterol linoleate, the devel-
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opment of atherosclerotic plaques is characterized by the
accumulation of cholesterol oleate within cells (25,26). This
is also the case for most types of experimentally induced
atherosclerosis. As plaques become more advanced, free
cholesterol and cholesterol linoleate from trapped plasma
also accumulate bound to extracellular connective tissue and
particularly in macrophages or cells derived from circulating
monocytes (26).
The possible ultrastructural and biochemical roles of
lipids in atherosclerotic plaque formation have been sum-
marized (8) in the following way: 1) It appears that a high
serum concentration of low density lipoprotein contributes
to the process of endothelial injury (27). 2) Studies with
smooth muscle cell cultures (27,28) suggest that lipoproteins
may be mitogenic, probably by contributing to cell mem-
brane formation. 3) The space occupying intracellular and
extracellular accumulations of fat also may contribute to the
growth of the atherosclerotic plaque (26). 4) It has been
suggested that factors that impair removal of cholesterol
from the arterial wall may favor its accumulation and, there-
fore, the progression ofthe disease. Conversely, recent stud-
ies (29,30) have established a consistent correlation between
high concentrations of high density lipoproteins in plasma
and a decreased incidence and progression of atherosclerotic
disease. Because high density lipoprotein molecules traverse
the arterial wall easily and are able to transport cholesterol
out of aortic smooth muscle cells in culture, it has been
suggested that the observed protection against atheroscle-
rosis is related to this removal of cholesterol from the arterial
wall. 5) There is evidence that lipoproteins enhance platelet
reactivity (31); as discussed later in regard to the patho-
genesis of advanced atherosclerotic lesions, this enhance-
ment of platelet reactivity may explain the increased throm-
bogenicity of an ulcerated atherosclerotic plaque in which
the arterial wall fat may come in contact with circulating
platelets.
Pathogenesis of the Advanced and
Complicating Atherosclerotic Plaques
Early coronary artery atherosclerotic lesions, particularly
in the form of fatty streaks, are a universal phenomenon in
young persons; however, the evolution into clinically rel-
evant lesions frequently occurs in those with the so-called
risk factors of atherosclerotic disease (Fig. 1, Table 1). We
now have experimental, pathologic and clinical evidence
that the early atherosclerotic lesions can progress to the
advanced and clinically relevant atherosclerotic plaques by
at least two completely different pathogenetic processes.
One is related to a continuation of the process responsible
for the development of the early atherosclerotic lesions as
described previously-a chronic phenomenon leading to a
slow progression of the atherosclerotic plaque over a period
of decades (Fig. 2A, B and C) (8). The second involves
complicating anatomic events, one of them related to a
thrombogenic process. Indeed, atherosclerotic plaques, par-
ticularly those of an already moderate or significant degree,
may progress very rapidly by means of superimposed plate-
let and fibrin thrombi (Fig. 2D), which then tend to undergo
phagocytosis and fibrotic atherogenic transformation (Fig.
2E) (32,33). It is likely that this fibrotic organization of
thrombi is also dependant on the activation of the smooth
muscle cells, not only by the platelet-derived growth factor,
but also probably by the fibrin itself as well as by the throm-
bin and plasmin generated in the thrombus media (14).
An important question to be answered is why does throm-
bus formation tend to occur over atherosclerotic plaques?
In this context there are at least three important aspects to
consider: 1) hemodynamic factors; 2) arterial damage, plaque
rupture and thrombogenicity; and 3) hypercoagulable state.
Hemodynamic factors. In regions of focal arterial nar-
rowing, there is a significant wall shear stress (force parallel
to lumen surface and independent of turbulence) with wide
variations in the direction of these forces (34). These ob-
servations are of particular significance in view of the cal-
culations that forces at or exceeding the yield stress of the
arterial surface lining may explain in part the superficial
damage to the arterial wall and, most important, the plaque
rupture that is characteristic of the complicated atheroscle-
rotic lesions. Other additional hemodynamic factors leading
to superficial arterial damage and plaque rupture may be
variations in blood pressure (35,36), changes in the vascular
tone (37) and even the normal bending and twisting of the
arteries which occur at every heart contraction (38).
Arterial damage, plaque rupture and thrombogen-
icity. There are two different types of arterial damage that
probably lead to thrombus formation over the atherosclerotic
plaques: 1) superficial damage mainly involving the endo-
thelial and subendothelial layers, and 2) deeper damage
mainly involving rupture, break, tear or ulceration of the
atherosclerotic plaque.
1) Superficial damage. This superficial damage is likely
related to the hemodynamic factors described earlier. It is
now evident experimentally that in such damaged areas there
is a significant tendency for platelet aggregation and throm-
bus formation (39,40). Contrary to the minimal endothelial
injury of the early atherosclerotic lesions, which appears to
lead only to platelet adhesion, this type of superficial arterial
damage in regions of arterial narrowing appears to be some-
what deeper, affecting the endothelial and subendothelial
layers and leading to platelet aggregation and thrombogen-
icity (Fig. 2D). That is, in these constricted arterial regions,
platelets easily become attached to the damaged surfaces as
a result of the same factors described for the endothelial
injury of the early atherosclerotic plaques (that is, Wille-
brand factor and collagen fibrils), and in this type of deeper
damage, the thrombogenicity is also favored by the absence
of two natural antithrombotic systems usually present in the
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intact endothelial and subendothelial arterial layer: the fi-
brinolytic system (41) and the prostaglandin system (par-
ticularly prostacyclin or prostaglandin Iz) (42),
In these stenotic regions of superficial arterial damage,
the clotting mechanism is activated during the processes of
platelet adhesion and aggregation and thrombin is generated,
further promoting the aggregation of platelets and, most
important, leading to the formation and polymerization of
fibrin, which maintains the stability and fixation of the ar-
terial thrombus (14), Such secondary superimposed depo-
sition of thrombus (mural thrombus) may undergo athero-
genesis with plaque growth (Fig, 2E) (32,33). In addition,
the thrombus may totally occlude the artery (occlusive
thrombus). However, in contrast to the regions of plaque
rupture described later, in these stenotic regions of super-
ficial arterial damage the thrombus is less fixed and may be
carried away by the high velocity flow and dissolved by the
intrinsic blood lytic system, Indeed, there is now increasing
evidence that in these atherosclerotic damaged regions where
thrombus tends to form there is a continuous dynamic for-
mation and disappearance of platelet thrombi (40) as well
as fluctuating vasotonicity (40,43). Both of these intermit-
tent phenomena may explain some of the intermittent coro-
nary artery syndromes,
2) Deep damage or plaque rupture: the complicating
lesions. Arteries that have advanced atherosclerotic lesions
(Fig. 3) often have an alteration and fragmentation of their
elastic elements (44,45) as well as softening related to the
fatty "gruel," particularlyat the margin of the plaque (35,46).
With such a fragile atherosclerotic plaque, it is not surprising
that addition of the hemodynamic factors may lead to plaque
rupture, tearing or ulceration.
Stepwise histologic sectioning ofthe coronary artery sys-
tem, including 100 to 1,000 sections of each segment with
complicating thrombosis, has revealed the following infor-
mation. Rupture, cracking or ulceration of atherosclerotic
plaques is a common autopsy finding in patients with coro-
nary atherosclerotic disease (35,36,38,46,47), In more than
half of the ruptured atherosclerotic plaques, the predominant
feature is hemorrhage from the lumen through the break
(dissecting hemorrhage); this type of rupture tends to occur
in plaques causing stenosis of 50 to 85% of the coronary
lumen (38), and usually the hemorrhage does not cause any
further compromise of the coronary lumen. Nearly half of
the ruptured atherosclerotic plaques reveal hemorrhage and
associated mural or occlusive thrombi; such ruptures com-
plicated by thrombi tend to occur in plaques causing stenosis
of more than 85% of the coronary artery lumen and the
thrombi cause further compromise of the lumen (4,38), Con-
versely, and most important, the majority of the compli-
cating coronary artery thrombi (80 to 100%) are anchored
in cracks or ruptured atherosclerotic plaques; the part of the
thrombus directly overlying the fissure is predominantly
platelet-related (35,38).
Thus, with meticulous histologic sectioning, a frequent
finding at autopsy in cases of acute myocardial infarction
is an acute ruptured and hemorrhagic atherosclerotic plaque
at the site of the complicating occlusive thrombus that pre-
Figure 3. A, Thrombus over a fissure of
the capsule of a fibrous plaque. The ma-
terial in the lower half of the field is the
collagen of the atheroscleroticarterial wall.
The thrombus (the mass in the upper field)
is anchored in the break of the underlying
atheroma capsule. The part of the throm-
bus directly overlying the fissure is rich
in "white" components (leukocytes,
platelets and fibrin). B, Thrombus mixed
with gruel over a wide tear in the collagen
of a fibrous coronary plaque. C, Throm-
bus over a wide gap in the capsule of an
atheroma, The thrombus (the reticular
material in the upper field) has developed
over the exposed gruel (the material with
the cholesterol clefts in the lower field).
The broken end of the atheroma capsule
can be seen just to the right of center and
the original arterial wall is at the extreme
left. D, Occlusive thrombus over a crack
at left lower margin of an atheroma at the
junction of the atheroma capsule with
the original coronary artery wall. Some
bleeding has occurred through the fissure
into the lower part of the atheroma. (Re-
produced from Constantinides P [35] with
permission. )
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sumably contributed to the infarction (48,49). In addition,
and probably more commonly than in the regions of su-
perficial damage previously described, in these ruptured
plaques the complicating thrombi may stabilize and be par-
tially occlusive or mural, leading to atherogenesis and plaque
growth (32,33).
In the genesis of thrombi as a complication of ruptured
atherosclerotic plaques, in addition to the thrombogenic
factors when the damage is superficial, as discussed earlier
(that is, collagen fibrils and absence of fibrinolytic system
and prostaglandin Iz), there are three other important factors
to be considered: I) when the atherosclerotic plaque ruptures
and hemorrhage enters the plaque, adenosine diphosphate
released from erythrocytes probably contributes to the pro-
cess of platelet aggregation (50); 2) in the advanced ath-
erosclerotic plaque the accumulated fat is usually underneath
but, when the plaque ruptures, such fat can come in contact
with the circulating blood and activate platelets and promote
thrombogenicity (31,51); and 3) the acutely damaged site
of the vascular wall can generate tissue thromboplastin which
also promotes thrombosis (52).
Hypercoagulable state. Focal thrombosis can lead to a
secondary hypercoagulable or thrombotic state which may
favor progression or recurrence of thrombi (14). However,
it is not entirely clear whether a primary hypercoagulable
or thrombotic state that can favor focal thrombosis and ath-
erosclerosis really exists. Platelet aggregation and the sub-
sequent generation of thrombin may be activated by cir-
culating catecholamines (53). This interrelation may be of
major importance because it may be a link between con-
ditions of stress and the development of arterial thrombosis
(54). Of no less importance is the increasing evidence of
an enhanced platelet reactivity in cigarette smokers (55), in
patients with a strong family history of coronary artery dis-
ease (55), in patients with hyperlipidemia (31) and those
with diabetes mellitus (56). However, it is conceivable that
in such high risk conditions for atherosclerotic and throm-
botic disease, the enhanced platelet reactivity and coagu-
lability may be a secondary phenomenon rather than a pri-
mary conditioner of the disease.
Thrombosis and the Coronary Syndromes
Including Sudden Death
Unstable angina pectoris. Analysis of coronary artery
anatomy has revealed that the distribution of lesions, the
number of diseased vessels and the percent stenosis in pa-
tients with unstable angina is similar to that in patients with
stable angina (57). However, because these studies did not
identify the coronary anatomy before the onset of unstable
angina, their significance is unclear. Recently, Moise et al.
(58) found progression of coronary artery disease in 76%
of patients with stable angina restudied after an episode of
crescendo angina and progression in a previously healthy
segment. This may imply complicating or rapidly progres-
sive lesions as the cause of the syndrome.
Indeed, our recent data identify a specific configuration,
on routine coronary angiography, in the majority of patients
with unstable angina presenting as either new onset or cre-
scendo angina. An asymmetric eccentric lesion with a nar-
row neck or irregular borders, or both, was found in 73%
of "angina-producing" coronary vessels in patients with
unstable angina, but in only 16% in patients with stable
angina (59). It has been suggested by postmortem angiog-
raphy and pathologic analysis that such eccentric angio-
graphic lesions represent ruptured atherosclerotic plaques
with or without associated thrombi (60).
In fact, 6 to 45% ofpatients with unstable angina have
some angiographic evidence of occlusive thrombi (61-64).
In this context it is important to appreciate that more than
10% of patients with unstable angina develop myocardial
infarction or die suddenly within 12 weeks of its onset (65).
Furthermore, there is increasing evidence that a substantial
percent of such events may be prevented by antithrombotic
therapy in the form of platelet inhibition (66) or heparin
(67). Finally, intermittent thrombosis or spasm over a su-
perficially damaged or ruptured plaque may explain some
of the cases of unstable angina that manifest as intermittent
resting angina (40,43).
Myocardial infarction. Until recently, most of our
knowledge about the lesions associated with transmural in-
farction had been derived from autopsy studies. Although
helpful, these studies represent a highly selected sample of
the population. In addition, the autopsy may have been
performed in patients who died suddenly (less than 6 hours
after the onset of symptoms) or who died days to weeks
after the infarction. Morphologic confirmation of infarction
is rarely possible within 6 hours of the onset of symptoms,
and the meaning of pathologic findings observed days to
weeks after infarction may be obscured by antemortem re-
canalization of the thrombus or by postmortem thrombolysis
and thrombus retraction from the arterial wall (32,68,69).
In addition, there are important differences in the methods
used to examine the coronary arteries. This variability in
groups studied and methods used in autopsy series is re-
flected in the reported incidence of thrombosis associated
with transmural infarction; this rate has ranged from about
20 to about 95% (70).
DeWood et al. (71) were the first to use coronary arte-
riography systematically to define the prevalence of total
coronary artery occlusion in the early hours after transmural
myocardial infarction. Total coronary occlusion was ob-
served in 87% of patients who were evaluated within 4 hours
after the onset of symptoms; this proportion decreased to
65% when patients were studied 6 to 24 hours after the onset
of symptoms. Among patients with angiographic features
of coronary artery thrombosis, the thrombus was retrieved
by Fogarty catheter in 88%. Thus, total coronary artery
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occlusion is frequent during the early hours of transmural
infarction and decreases in frequency during the initial 24
hours, suggesting that coronary spasm or thrombus for-
mation with subsequent recanalization or both may be im-
portant in the evolution of infarction.
Recent early postinfarction angiographic studies (72) of
the efficacy of thrombolytic therapy to restore perfusion of
the infarct-related coronary artery have indicated that throm-
botic coronary artery occlusion probably plays a role in
about 60 to 90% of transmural myocardial infarcts and in
a lesser number of subendocardial myocardial infarcts (the
importance of rupture of a significantly stenotic atheroscle-
rotic plaque in the genesis of the thrombus was discussed
earlier in this paper). In addition, spontaneous lysis of the
thrombus and recurrence of the occlusion are frequent phe-
nomena; such processes appear to be favored by the use or
nonuse of anticoagulation in the postinfarction period,
respectively.
Sudden death due to coronary disease. In most cases
of sudden unexpected death, there is little doubt that the
terminal event is some form of electrical instability of the
heart (73). Considered from a numerical standpoint, the
majority of such sudden deaths occur in persons with ex-
tensive coronary artery disease (73,74). The electrocardio-
graphic diagnosis of acute myocardial infarction or ischemia
in resuscitated survivors provides a more accurate estimate
of the incidence of acute myocardial involvement in sudden
coronary death than does standard histologic examination,
which may give unremarkable results at this early stage
(32,68,69). Electrocardiographic evidence of acute myo-
cardial infarction and, more commonly, ischemia, has been
noted in nearly three-quarters of these patients (74,75). This
may indicate a decrease in coronary blood supply as a result
of an acute coronary artery lesion. Indeed, acute compli-
cated coronary artery lesions were found at autopsy in nearly
three-quarters of the patients (75,76), and the majority were
consistent with plaque rupture and resultant thrombus for-
mation as described earlier. In the remaining quarter of the
patients, sudden coronary death appeared to be associated
with a fibrotic myocardium (previous myocardial infarction)
or other alterations (74,75).
On the basis of the previous information, it is not unrea-
sonable to consider thrombus formation in the coronary
arteries as a frequent factor precipitating sudden death.
The question is whether the terminal electrical instability of
the heart is an ischemic response to the complicated coronary
obstruction or to intramyocardial thromboemboli that orig-
inate from the coronary lesion and lodge within small ves-
sels. The importance of the intramyocardial thromboemboli
in contributing to death is more conjectural. By analogy
with thrombi in the carotid artery and transient cerebral
ischemic attacks, the coronary thrombi could be a source
of emboli consisting predominantly of platelets that are car-
ried into the myocardium. Such emboli could give rise to
transient myocardial ischemia and sudden ventricular fi-
brillation. Clinical assessment of the frequency of such em-
boli is impossible because they are so small and, unlike the
retina, the myocardium cannot be visualized in life. Some
previous pathologic studies of sudden death have found
morphologic evidence of intramyocardial platelet emboli
within small vessels (77,78). However, the frequency was
not much higher than that in control patients.
It can be concluded that, in a high proportion of cases
of sudden coronary death, the pathologic process probably
involves a rapidly evolving coronary artery lesion in which
plaque fissure and resultant thrombus formation lead to an
ischemic and fatal electrical instability of the heart. Whether
intramyocardial platelet emboli play a role in some cases
of sudden coronary death is debatable and difficult to prove.
The Role of Platelet-Inhibiting Drugs
Because of the evolving importance of platelets in the
pathogenesis of atherosclerotic disease and its complica-
tions, a brief statement on the role of platelet inhibitors is
pertinent. This discussion will focus on the two different
mechanisms of atherosclerotic plaque progression: slow pro-
gression of the early atherosclerotic lesions toward the ad-
vanced atherosclerotic plaques and rapid thrombogenic pro-
gression and complications of the advanced atherosclerotic
plaques.
The slow process of atherosclerotic progression.
There is evidence that platelet-arterial wall interaction is an
important step in the pathogenesis of the early atheroscle-
rotic lesions and of the slow progression of advanced ath-
erosclerotic plaques. Indeed, it appears that the minimal
endothelial injury caused by chronic hemodynamic turbu-
lence and by some of the so-called risk factors of athero-
sclerotic disease may lead to intermittent platelet-arterial
wall interaction and the slow development of atherosclerotic
lesions. We have been able to reproduce such minimal endo-
thelial injury in the experimental pig (without desquamation
of the endothelial cells from the subendothelial layer) (79);
a single layer of platelets interacting with the damaged en-
dothelium appears to be sufficient to induce the intimal
smooth muscle cell proliferation compatible with the ath-
erosclerotic lesion. The important point is that currently
there is no platelet-inhibitor drug available that can totally
prevent adherence of this single layer of platelets. Therefore,
we think that the use of platelet-inhibiting drugs will not
prevent the slow atherosclerotic process.
If a new platelet-inhibiting drug that can totally prevent
platelet adhesion to the vessel wall becomes available in
the future. then a new risk will emerge: the risk ofbleeding.
Pigs with homozygous von Willebrand's disease have a
marked impairment in platelet attachment to the vascular
wall (79) and are resistant to the initiation and progression
of atherosclerotic disease (17,18), but they have a severe
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bleeding tendency. On the other hand, pigs that have less
severely impaired platelet-arterial wall interaction, that is,
have heterozygous von Willebrand's disease, develop ath-
erosclerosis but are free of significant bleeding (80). Also,
Friedman et al. (81) produced marked thrombocytopenia
(platelet count < 7,OOO/mm3) in rabbits by administering
antiplatelet antiserum. Injury of the endothelium in these
rabbits with a polyethylene catheter was not followed by
the development of atherosclerotic lesions, but the animals
had a significant bleeding tendency; however, rabbits with
less severe thrombocytopenia were not protected from
atherosclerosis.
These findings emphasize that prevention of the initiation
and progression of the slow atherosclerotic process in the
arteries might be accomplished only if platelet function and
platelet count decreased to the point of causing significant
bleeding. Therefore, it is not unreasonable to think that only
those platelet-inhibiting agents that cause severe platelet
dysfunction and bleeding might be of benefit in preventing
the progression of the slow atherosclerotic process. Such
agents are not yet available, and we think are undesirable.
In practical terms, for the slow progression of atheroscle-
rosis, which tends to occur in a period of decades, preven-
tion and modification of the risk factors for atherosclerotic
disease should be the fundamental approach.
The rapid process of atherosclerotic progression and
thrombogenic complications. In some patients with ad-
vanced atherosclerotic plaques, such plaques continue to
progress rapidly or become complicated by a thrombogenic
mechanism that can lead to some of the acute coronary artery
syndromes. Because platelet aggregation and arterial thrombi
appear to be essential in these cases, it is reasonable to
assume that platelet-inhibiting drugs may be of benefit. On
the basis of the striking antithrombotic effect obtained with
these drugs in the saphenous vein graft model (82,83), we
believe that these agents may tum out also to be of benefit
in the prevention of the rapid thrombogenic atherosclerotic
process and some of the thrombotic complications of coro-
nary artery disease. A recent drug trial (66) and some other
studies in progress (84) with different methodologic prin-
ciples and end points (3,85,86) may substantiate this belief.
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